MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$231,152
-4.9%
3,206
-3.0%
0.00%0.0%
Q1 2023$243,042
+8.2%
3,304
-1.8%
0.00%0.0%
Q4 2022$224,715
-18.3%
3,364
+5.4%
0.00%
-25.0%
Q3 2022$275,000
+8.7%
3,191
+12.7%
0.00%
+33.3%
Q2 2022$253,000
-6.6%
2,832
+17.7%
0.00%0.0%
Q1 2022$271,000
-23.2%
2,407
+5.4%
0.00%
-25.0%
Q4 2021$353,000
+13.9%
2,284
+2.7%
0.00%
+33.3%
Q3 2021$310,000
-83.9%
2,224
-84.8%
0.00%
-84.2%
Q2 2021$1,920,000
-15.1%
14,638
-1.3%
0.02%
-20.8%
Q1 2021$2,262,000
+49.9%
14,837
-2.2%
0.02%
+41.2%
Q4 2020$1,509,000
+4.7%
15,174
+0.4%
0.02%
-10.5%
Q3 2020$1,441,000
-13.7%
15,118
+1.3%
0.02%
-20.8%
Q2 2020$1,669,000
+49.7%
14,919
-2.7%
0.02%
+26.3%
Q1 2020$1,115,000
-33.7%
15,331
-4.9%
0.02%
-9.5%
Q4 2019$1,681,000
-0.6%
16,114
-5.1%
0.02%
-12.5%
Q3 2019$1,691,000
-14.6%
16,987
-2.0%
0.02%
-14.3%
Q2 2019$1,979,000
-12.4%
17,339
-3.5%
0.03%
-15.2%
Q1 2019$2,259,000
-11.4%
17,969
-4.4%
0.03%
-21.4%
Q4 2018$2,551,000
+2219.1%
18,799
+4588.0%
0.04%
+2000.0%
Q3 2018$110,000
+587.5%
401
+414.1%
0.00%
Q2 2018$16,000
-36.0%
78
-80.5%
0.00%
-100.0%
Q2 2014$25,0004000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders